key: cord-0989213-cf0zvp79
authors: Morf, Harriet; Krusche, Martin; Knitza, Johannes
title: Patient self-sampling: a cornerstone of future rheumatology care?
date: 2021-04-10
journal: Rheumatol Int
DOI: 10.1007/s00296-021-04853-z
sha: cc9e3c538a777a5f228d03916a24d1043053f66e
doc_id: 989213
cord_uid: cf0zvp79

nan

A pilot study showed that blood microsampling is a feasible and accurate method for monitoring hydroxychloroquine levels in rheumatoid arthritis patients [6] . Inflammatory markers, such as C-reactive protein (CRP), are especially crucial in the evaluation of inflammatory disease activity (i.e. DAS-28 or ASDAS), however, to our knowledge, only point-of-care tests [7] have yet been used.

We believe that COVID-19 will not only accelerate digitalisation in rheumatology care [3] , but also in patient selfsampling. We recently reported that COVID-19 increased the acceptance of digital health applications among rheumatologists (n = 129) and patients (n = 299) in Germany [8] . Despite the current experimental status of self-sampling, we observed high acceptance rates among patients and rheumatologists. To our knowledge, this is the first published work to explore the acceptance of self-sampling in rheumatology. 128 (44%) of patients and 50 (39%) of rheumatologists were interested in using self-sampling in the future. Interestingly, male patients tended to be more in favour of self-sampling than female patients (67% compared to 43%) (r = 0.001, p = 0.001). Furthermore, patients under the age of 60 years stated that they were more likely to use self-sampling in the future (p = 0.05; r = 0.137). Especially patients with spondyloarthritis (generally younger patients) expressed a positive opinion (53.7%) concerning self-sampling. Additionally, we observed a positive correlation between the travel time to the rheumatologist and interest in self-sampling in male patients. In the case of more than 30 min travel time, we observed a significant correlation with interest in selfsampling (p = 0.027; r = 0.418).

The advancement of self-sampling in rheumatology enables need adapted, low burden, patient-centered, flexible blood collection, ultimately empowering patients, rheumatologists and researchers alike. 

Conflict of interest Nothing to disclose for any of the authors.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding

Rapid distribution of information by SMS-embedded video link to patients during a pandemic

Digital health: a new dimension in rheumatology patient care

Self-Monitoring of Blood Glucose|Diabetes Technology & Therapeutics

Self-monitoring and self-management of oral anticoagulation

Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients

Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa

Digital rheumatology in the era of COVID-19: results of a national patient and physician survey